Spain · AEMPS CIMA
CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72690
- Form
- SUSPENSIÓN ORAL
- Composition / generic term
- cloperastina
- Source strength
- 3,54 mg cloperastina fendizoato/ml de suspensión
- Authorisation holder
- Laboratorios Cinfa S.A.
- Marketed in source snapshot
- Yes
Source-listed ingredients
- CLOPERASTINA FENDIZOATO — 3,54 mg
These values do not establish equivalence or a dose recommendation.
Packages
- CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL, 1 frasco de 120 ml (vidrio)
- CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL, 1 frasco de 200 ml (vidrio)
- CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL,1 frasco de 120 ml (PET)
- CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL,1 frasco de 200 ml (PET)
Source and coverage
Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Spain records →